Explore how advances in accuracy, throughput and cost are making long-read sequencing more accessible at scale.
Confirmed, pooled, blinded COVID-19 events in the ongoing Phase 3 DECLARATION study of VYD2311 accumulated to date (~ 50% of study progress) can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results